News
FDA expands Xofluza indication to include postexposure flu prophylaxis
November 25, 2020
“This expanded indication for Xofluza will provide an important option to help prevent influenza just in time for a flu season that is anticipated to be unlike any other.”
News
Rationale for baricitinib’s use in COVID-19 patients demonstrated
November 24, 2020
“We went from modeling and mechanistic investigations to clinical tests in a number of settings and laboratory analysis in record time,” Dr. Justin Stebbing said.
News
COVID-19 burdens follow patients after discharge
November 18, 2020
Postdischarge COVID-19 patients have high rates of long-term sequelae from sepsis and other severe respiratory viral illnesses.
News
Metapneumovirus infections clinically indistinguishable from flu, RSV
November 17, 2020
Those at risk for severe or fatal metapneumovirus infections include frail elderly and patients with cardiovascular disease or compromised immunity.
News
Biometric changes on fitness trackers, smartwatches detect COVID-19
November 5, 2020
Adding passively monitored physiologic data from wearable devices to self-reported symptom data enhances an app’s ability to discriminate between COVID-19 positivity and negativity, new data show.
News
About 17% of COVID-19 survivors retest positive in follow-up study
November 2, 2020
The findings could carry important implications for people who continue to be symptomatic.
News
COVID frontline physicians afraid to seek mental health care
October 29, 2020
“The pandemic emphatically underscores our need to change the status quo when it comes to physicians’ mental health,” said Dr. Mark Rosenberg.
News
Potentially practice-changing bacterial therapy trials analyzed
October 29, 2020
Intravenous fosfomycin could improve treatment of complicated UTIs, but adjunctive inhaled amikacin did not improve pneumonia outcomes in ventilated patients.
News
Vertebral fractures in COVID-19 linked to mortality
October 28, 2020
Radiologic thoracic vertebral fractures were found in one-third of COVID-19 patients who underwent lateral chest x-rays, and those patients were twice as likely to die.
News
COVID-19: Thromboembolic events high despite prophylaxis
October 27, 2020
“Standard prophylaxis as recommended in the guidelines is a low dose of low-molecular-weight heparin once daily, but these results suggest [patients] probably need higher doses.”